- Original article
- Open Access
Snail promotes metastasis of nasopharyngeal carcinoma partly by down-regulating TEL2
© The Author(s) 2018
- Received: 25 February 2018
- Accepted: 14 September 2018
- Published: 25 September 2018
Metastasis is the major cause of treatment failure in patients with nasopharyngeal carcinoma (NPC). We previously reported that TEL2, a negative regulator of SERPINE1, could inhibit NPC metastasis to lymph nodes.
A series of in vivo and in vitro assays were performed to elucidate the regulation between Snail and TEL2. TEL2 expression was analyzed in three representative NPC cell lines expressing low levels of Snail (S26, 6-10B, HK1) and two cell lines expressing high levels of Snail (S18, 5-8F). Luciferase and chromatin immunoprecipitation assays were used to analyze the interaction between Snail and TEL2. The roles of the Snail/TEL2 pathway in cell migration and invasion of NPC cells were examined using transwell assays. Metastasis to the lungs was examined using nude mouse receiving NPC cells injection through the tail vein.
Ectopic Snail expression down-regulated TEL2 at the mRNA and protein levels, whereas knockdown of Snail using short hairpin RNA up-regulated TEL2. Luciferase and chromatin immunoprecipitation assays indicated that Snail binds directly to the TEL2 promoter. Ectopic Snail expression enhanced migration and invasion of NPC cells, and such effects were mitigated by TEL2 overexpression. TEL2 overexpression also attenuated hypoxia-induced cell migration and invasion, and increased the number of metastatic pulmonary nodules. Snail overexpression reduced the number of metastatic pulmonary nodules.
TEL2 is a novel target of Snail and suppresses Snail-induced migration, invasion and metastasis in NPC.
- Nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is highly prevalent in southern China and Southeast Asia [1–4]. In 2013, 42,100 new cases of NPC were diagnosed in China, with 21,320 NPC-related deaths . Estimated rate of metastasis is 15%–30% despite of the exquisite sensitivity to radiation therapy [6, 7]. At the time of diagnosis, 74.5% of the patients have regional lymph node metastasis; 19.9% of the patients have distant metastasis, most often to the liver and lungs . Distant metastasis is the major cause of treatment failure [8–10].
TEL2 (also referred to as ETV7) is a member of the ETS transcription factor family, and plays a key role in hematopoiesis [11, 12]. In a previous study, we identified an inverse relationship between TEL2 expression and metastasis potential in NPC cell lines . We also showed EL2 inhibits NPC metastasis by binding to the promoter of SERPINE1 and down-regulating its expression .
Snail is a master regulator of epithelial-to-mesenchymal transition (EMT). High Snail expression is associated with high metastatic potential in colon cancer , liver cancer [14, 15], lung cancer , as well as NPC by our previous study . Based on these findings, we speculate that TEL2 is a down-stream effector of Snail.
The results of the current study indicated that Snail could down-regulate TEL2 via direct binding to promoter of the TEL2 gene. Consistent with such an action, Snail enhanced NPC cell migration invasion in cultured NPC cells and promoted metastasis to the lungs in nude mice carrying NPC xenograft.
The in vitro experiments were carried out in three representative NPC cell lines expressing low levels of Snail (S26, 6-10B, HK1) and two representative cell lines expressing high levels of Snail (S18, 5-8F) [2–4]. Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) supplemented with 10% fetal bovine serum (FBS; Gibco). All cell lines were authenticated using short-tandem repeat profiling within 6 months prior to the experiments. All five cell lines were obtained from Sun Yat-sen University Cancer Center (SYSUCC).
The full-length cDNAs of human TEL2 and Snail were cloned into pBABE-puro vector (Cell Biolabs, INC). An HA tag was inserted to the N-terminus of TEL2. The fusion protein Snail-T2A-TEL2, in which Snail and TEL2 were linked by a T2A linker, was also expressed using the pBABE-puro vector. Mutations were introduced using the Quick-Change Site-Directed Mutagenesis Kit (Stratagene), and verified with DNA sequencing.
Antibody against human TEL2 (Dilution, 1:1000) was obtained from Sigma (HPA029033). Antibodies against human Snail were obtained from R&D (AF3639) for chromatin immunoprecipitation (ChIP) assays and from Cell Signaling Technology (#3895) for Western blotting. Anti-E-cadherin antibody was obtained from BD Company. Antibodies against HA and Tubulin were obtained from Cell Signaling Technology. Antibody against human SERPINE1 was obtained from Santa Cruz (sc-5297).
Cell lines stably expressing short hairpin RNA (shRNA) targeting Snail transcripts or negative control scrambled shRNA were established using kits from Sigma. The sequences of the 2 human Snail shRNAs are: 5′-ATGCTCATCTGGGACTCTGTC-3′ and 5′-TGCTCCACAAGCACCAAGAGT-3′. Sequence of the short interfering RNA (siRNA) targeting human TEL2 is: 5′-GCCAGATGTGAAGCTCAAATTA-3′.
RNA extraction and qRT-PCR
These procedures were performed as described previously [3, 17, 18]. Briefly, total RNA was isolated using Trizol reagent (Invitrogen). First-strand cDNA was synthesized using the Revert Aid™ First Strand cDNA Synthesis Kit (MBI Fermentas). The primers were used to amplify target sequences (Additional file 1: Table S1).
Migration and invasion assays
For transwell migration assays, 1.5 × 104 cells (S18, 5-8F) or 3.5 × 104 cells (S26, 6-10B) in 200 μl of serum-free DMEM were added to cell culture inserts with an 8-μm microporous filter without extracellular matrix coating (Becton–Dickinson Labware). DMEM medium containing 10% FBS was added to the bottom chamber. After 24-h incubation, the cells in the lower surface of the filter were fixed, stained, and examined using a microscope. The numbers of migrated cells from triplicate filters were counted in three random optical fields (×100 magnification) and averaged.
Transwell invasion assays were carried out in the same way, except that the chamber inserts were precoated with Matrigel (Becton–Dickinson Labware).
Chromatin immunoprecipitation (ChIP) assay
The assay was conducted using a commercial ChIP kit from Active &Motif (cat#: 53040). Briefly, cells were seeded onto 15-cm plates and allowed to grow to 70%–80% confluence. Cells were fixed and collected, and the nuclear pellet was resuspended in ChIP Buffer, subjected to sonication and incubated overnight with 5-μg antibody, followed by incubation with protein G agarose beads for 3 h at 4 °C. DNA–protein complexes were eluted and de-cross-linked through a series of washes. Purified DNA was resuspended in TE buffer and analyzed with PCR using the following primers: E-cadherin-ChIP-F, 5′-ACTCCAGGCTAGAGGGTCACC-3′; E-cadherin-ChIP-R, 5′-CCGCAAGCTCACAGGTGCTTTGCAGTTCC-3′; TEL2-ChIP-E1-F, 5′-TGAATGTGCATTAGTTTATCAAGCC-3′; TEL2-ChIP-E1-R, 5′-CAATCTGCCTACCAGAAATTTATTC-3′; TEL2-ChIP-E2-F, 5′-CACAGTCACGGCTCACTGCAG-3′; TEL2-ChIP-E2-R, 5′-GAGTTGGACACCAGTCTGAACAAC-3′; TEL2-ChIP-E3-F, 5′-GGAGCGCTCAAGACAGAAAGC-3′; TEL2-ChIP-E3-R, 5′-AAAATAGGTTTGGAAATCTAGGTGG-3′; TEL2-ChIP-E4-F, 5′-AGGCAGTAGAGTGGTTAACACAAAC-3′; TEL2-ChIP-E4-R, 5′-TTTATGGAGTTCTCTGTGGATCATG-3′; GAPDH-ChIP-F, 5′-TTCTTGCCTTGCTCTTGCTACTC-3′; and GAPDH-ChIP-R, 5′-AGCCTGCCTGGTGATAATCTTTG-3′.
The assay was carried out as described previously [2, 4]. Briefly, cells were plated in 12-well plates at a density of 2 × 105 per well, and transfected with 0.8-μg promoter-luciferase plasmid. To normalize transfection efficiency, cells were co-transfected with 8-ng pRL-CMV encoding Renilla luciferase. After transfection for 48 h, luciferase activity was measured using the Dual-Luciferase Assay kit (Promega). Three independent experiments were performed, and means and standard deviations are presented.
Experiments involving animal subjects and all protocols for animal studies were approved by the Research Animal Resource Center of Sun Yat-sen University, in full compliance with the guidelines of the Institutional Animal Care and Use Committee at Sun Yat-sen University Cancer Center. Male athymic mice aged 5–6 weeks were obtained from Shanghai Institutes for Biological Sciences (Shanghai, China). Human NPC cells were resuspended in 100-μl phosphate-buffered saline (PBS; Biological Industries) and injected into the lateral tail vein of mice (3 × 106 cells/animal). At 6 weeks after injection, mice were euthanized. Metastatic nodules were counted with the naked eyes.
Experiments involving human tissue samples were approved by the Institutional Review Board of Sun Yat-sen University Cancer Center (YB2015-010). Written informed consent was obtained from all subjects prior to sample collection. Tissue blocks prepared from NPC tissues (10 cases) and lymph node metastases (4 cases) were stored for qRT-PCR.
Differences between two groups were assessed using Student’s t-test. Differences among three or more groups were assessed using parametric ANOVA and the least significant difference (LSD) test. Statistical significance was set at P < 0.05 (2-sided).
Snail down-regulates TEL2
Snail binds directly to the TEL2 promoter
Snail is involved in hypoxia-induced TEL2 down-regulation
A Snail/TEL2/SERPINE1 axis functions
Snail promotes NPC cell migration and invasion by down-regulating TEL2
Snail promotes NPC metastasis by down-regulating TEL2
The current study showed, for the first time, that TEL2 is a target of Snail in NPC. Snail is a key transcription factor that regulates cancer metastasis mainly by down-regulating E-cadherin, a key player during EMT and the reverse transition of mesenchymal-to-epithelial transition (MET). Our finding that TEL2 is a downstream target of Snail may explain why Snail overexpression up-regulates SERPINE1, as previously reported [20, 21]. Snail down-regulates TEL2, which in turn down-regulates SERPINE1. Results from the current study suggest that the Snail/TEL2/SERPINE1 axis plays a key role in NPC metastasis.
Hypoxia is present in most NPC tumors, and could promote cancer metastasis [22, 23]. Consistent with a previous study reporting Snail induction by hypoxia , we showed increased Snail expression and decreased expression of TEL2 and E-cadherin upon hypoxia in cultured NPC cells. We speculate that the same processes occur in NPC tumors and mediate the ability of hypoxia to promote NPC metastasis.
Snail down-regulates TEL2 in NPC cells and tissues under both normoxic and hypoxic conditions, ultimately leading to up-regulation of SERPINE1, which promotes metastasis (Fig. 6d). This novel pathway may be valuable for designing new treatments for patients with NPC metastasis.
Conception and design: YS and TK. Development of methodology: YS and CC. Data acquisition: YS and CC. Data analysis and interpretation: YS and CC. Drafting and revision of the manuscript: YS and TK. Study supervision: TK. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Availability of data and materials
Key raw data have been deposited into the Research Data Depository (http://www.researchdata.org.cn) under Approval No. RDDB2018000378.
Consent for publication
Ethics approval and consent to participate
Animal experiments were approved by the Animal Research Committee of Sun Yat-sen University Cancer Center and were performed in accordance with established guidelines. The use of human NPC tissues was reviewed and approved by the Ethics Committee of Sun Yat-sen University Cancer Center, and patient informed consent was obtained. Samples were retrospectively acquired from the surgical pathology archives of Sun Yat-sen University Cancer Center.
This work was supported by grants to YS from the National Science Foundation of China (81660449), the Jiangxi Provincial Natural Science Foundation of China (20161ACB21001, 20171BCD40026), and the Jiangxi Provincial Health and Family Planning Commission Foundation (20164005, 2015A077); as well as by a grant to TK from the Science and Technology Program of Guangzhou, China (201508020102).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Bei JX, Li Y, Jia WH, et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet. 2010;42(7):599–603.View ArticleGoogle Scholar
- Sang Y, Chen MY, Luo D, et al. Tel2 suppresses metastasis by down-regulating serpine1 in nasopharyngeal carcinoma. Oncotarget. 2015;6(30):29240–53.View ArticleGoogle Scholar
- Sang Y, Wang L, Tang JJ, et al. Oncogenic roles of carbonic anhydrase ix in human nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2014;7(6):2942–9.PubMedPubMed CentralGoogle Scholar
- Wang L, Sang Y, Tang J, et al. Down-regulation of prostate stem cell antigen (psca) by slug promotes metastasis in nasopharyngeal carcinoma. J Pathol. 2015;237(4):411–22.View ArticleGoogle Scholar
- Wei KR, Zheng RS, Zhang SW, et al. Nasopharyngeal carcinoma incidence and mortality in china, 2013. Chin J Cancer. 2017;36(1):90.View ArticleGoogle Scholar
- Sun X, Su S, Chen C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110(3):398–403.View ArticleGoogle Scholar
- Tang XR, Li YQ, Liang SB, et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol. 2018;19(3):382–93.View ArticleGoogle Scholar
- Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern china. BMC Cancer. 2006;6:178.View ArticleGoogle Scholar
- Colaco RJ, Betts G, Donne A, et al. Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre. Clin Oncol. 2013;25(3):171–7.View ArticleGoogle Scholar
- Wang MH, Sun R, Zhou XM, et al. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway. Cell Death Dis. 2018;9(1):2.View ArticleGoogle Scholar
- Carella C, Potter M, Bonten J, et al. The ets factor tel2 is a hematopoietic oncoprotein. Blood. 2006;107(3):1124–32.View ArticleGoogle Scholar
- Gu X, Shin BH, Akbarali Y, et al. Tel-2 is a novel transcriptional repressor related to the ets factor tel/etv-6. J Biol Chem. 2001;276(12):9421–36.View ArticleGoogle Scholar
- Jagle S, Busch H, Freihen V, et al. Snail1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells. PLoS Genet. 2017;13(11):e1007109.View ArticleGoogle Scholar
- Kuo TC, Chen CK, Hua KT, et al. Glutaminase 2 stabilizes dicer to repress snail and metastasis in hepatocellular carcinoma cells. Cancer Lett. 2016;383(2):282–94.View ArticleGoogle Scholar
- Qin Y, Zhao D, Zhou HG, et al. Apigenin inhibits nf-kappab and snail signaling, emt and metastasis in human hepatocellular carcinoma. Oncotarget. 2016;7(27):41421–31.View ArticleGoogle Scholar
- Zhang Y, Zhang X, Ye M, et al. Fbw7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of snail protein. Cancer Lett. 2018;419:75–83.View ArticleGoogle Scholar
- Lv XB, Liu L, Cheng C, et al. Sun2 exerts tumor suppressor functions by suppressing the warburg effect in lung cancer. Sci Rep. 2015;5:17940.View ArticleGoogle Scholar
- Yin Y, Zhong J, Li SW, et al. Trim11, a direct target of mir-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer. Oncotarget. 2016;7(52):86755–65.View ArticleGoogle Scholar
- Shalem O, Sanjana NE, Hartenian E, et al. Genome-scale crispr-cas9 knockout screening in human cells. Science. 2014;343(6166):84–7.View ArticleGoogle Scholar
- Moreno-Bueno G, Cubillo E, Sarrio D, et al. Genetic profiling of epithelial cells expressing e-cadherin repressors reveals a distinct role for snail, slug, and e47 factors in epithelial-mesenchymal transition. Cancer Res. 2006;66(19):9543–56.View ArticleGoogle Scholar
- Fabre-Guillevin E, Malo M, Cartier-Michaud A, et al. Pai-1 and functional blockade of snai1 in breast cancer cell migration. Breast cancer research (BCR). 2008;10(6):R100.View ArticleGoogle Scholar
- Hong B, Lui VW, Hashiguchi M, et al. Targeting tumor hypoxia in nasopharyngeal carcinoma. Head Neck. 2013;35(1):133–45.View ArticleGoogle Scholar
- Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res. 2010;16(24):5928–35.View ArticleGoogle Scholar